Form 4: Allogene Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4
Geoffrey M. Parker, CFO of Allogene Therapeutics, sold 4,361 shares of common stock on February 3, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 3, 2025, Geoffrey M. Parker, the Chief Financial Officer of Allogene Therapeutics, Inc., sold 4,361 shares of the company's common stock.
- The sale was executed at a price of $1.73 per share.
- This transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Parker directly owns 1,301,540 shares of Allogene Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sell to cover taxes) and doesn't indicate any significant positive or negative sentiment.
Industry Context
Sales to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of the stock sale transaction. |
| 02/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.